Cognitive Impairment Clinical Trial
Official title:
A Multicomponent Intervention to Rehabilitate Cognitive Impairment in People Post-stroke: Single-arm Feasibility Study
NCT number | NCT05414539 |
Other study ID # | OptiCogs |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 9, 2022 |
Est. completion date | June 30, 2022 |
Verified date | February 2022 |
Source | University of Limerick |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
OptiCogs Online is a complex multicomponent intervention comprising of cognitive, physical activity and educational components.
Status | Completed |
Enrollment | 9 |
Est. completion date | June 30, 2022 |
Est. primary completion date | June 24, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - People with a physician-confirmed diagnosis of stroke. Stroke may be ischaemic or haemorrhagic in nature. - People aged =18 years old; with confirmed mild to moderate cognitive impairment using the Oxford Cognitive Screen (OCS) (in accordance with cut-offs for impairment for OCS-plus subtasks (Demeyere et al. 2021a) and the Addenbroke's Examination III (ACE III) with a cut-off score of 88/100 (Takenoshita et al. 2019). - People post-stroke who have a Modified Rankin Scale (MRS) score of 0-3 - Capacity to provide informed consent - People post-stroke who are able to express their basic needs, verbally or not - Have access to a smartphone, laptop or tablet with an internet connection - Willingness/ interest in participating in an online intervention - Physician-confirmed suitability to partake in this intervention Exclusion Criteria: - Physician-confirmed contraindications for undertaking physical activity e.g., safety, presence of unstable heart disease - People with diagnosed TIA will be excluded - People post-stroke with known active delirium or dementia will be excluded - People post-stroke with a diagnosis of known pre-stroke cognitive impairment - People post-stroke with moderate or severe visuospatial neglect |
Country | Name | City | State |
---|---|---|---|
Ireland | University of Limerick | Limerick |
Lead Sponsor | Collaborator |
---|---|
University of Limerick |
Ireland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Recruitment rate | The proportion of participants who are recruited to the study. | 6 weeks | |
Primary | Adherence rate | The proportion of participants who adhere to the treatment protocol of 6 weeks. We will determine the level of adherence to the intervention protocol using the self-report diary. | 6 weeks | |
Primary | Adverse events | Number of participants with adverse events as a measure of safety. Adverse events include a fall, illness, medical complication etc. | 6 weeks | |
Primary | Acceptability of OptiCogs Online | The proportion of participants reporting that OptiCogs Online is acceptable. Acceptability (satisfaction) of the OptiCogs intervention will be assessed using a self-report questionnaire developed by the researchers containing 5-point Likert scales: 1= "strongly disagree"; 2= "disagree"; 3= "neutral"; 4= "agree"; 5= "strongly agree". | 6 weeks | |
Primary | Retention rate | The proportion of participants who are lost to follow-up | 6 weeks | |
Secondary | Oxford Cognitive Screen-plus (OCS-plus) | Changes in cognitive function from pre-intervention to post-intervention in accordance with the cut-offs for impairment for OCS-Plus subtasks. | 6 weeks | |
Secondary | Addenbrooke's Cognitive Assessment (III) ACE (III) | Changes in cognitive function from pre-intervention to post-intervention in accordance with ACE III score out of 100. | 6 weeks | |
Secondary | Fatigue severity scale (FSS) | ). The FSS is a 9-item scale which measures the severity of fatigue and its effect on ADLs on a 7-point scale. The FSS is shown as a valid and reliable measure of fatigue in people post-stroke | 6 weeks | |
Secondary | PROMIS-10 Physical Functioning | • Physical function (PF) will be assessed using a physical functioning subset of the patient reported outcomes measurement information system (PROMIS) scale. | 6 weeks | |
Secondary | Stroke Specific Quality of Life Scale | • Mood and social participation will be assessed using the relevant subscales of the Stroke-Specific Quality of Life Scale-12 (SSQoL-12). | 6 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02122198 -
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
|
N/A | |
Recruiting |
NCT04356924 -
Psychological Treatment to Support the Consequences of Cognitive Impairment
|
N/A | |
Suspended |
NCT05542238 -
The Effect of Acute Exercise on Cardiac Autonomic, Cerebrovascular, and Cognitive Function in Spinal Cord Injury
|
N/A | |
Terminated |
NCT04493957 -
Evaluation of an Educational Program in the Prevention of the Driving Risks in Patients With Neurocognitive Disorders : ACCOMPAGNE
|
N/A | |
Recruiting |
NCT04792983 -
Cognition and the Immunology of Postoperative Outcomes
|
||
Completed |
NCT06029920 -
Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment
|
N/A | |
Not yet recruiting |
NCT05068323 -
Impact of Interictal Epileptiform Activity on Some Cognitive Domains in Newly Diagnosed Epileptic Patients
|
N/A | |
Completed |
NCT04426838 -
Cognitive Behavioral Therapy for Insomnia for the Dementia Caregiving Dyad
|
N/A | |
Completed |
NCT04713384 -
Remote Bimanual Virtual Rehabilitation Post CVD
|
N/A | |
Recruiting |
NCT06284213 -
Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium
|
||
Recruiting |
NCT06053775 -
Non-Invasive Brain Stimulation and Cognitive Training for Depressive Symptomatology Related to Breast Cancer (ONCODEP)
|
N/A | |
Completed |
NCT03698695 -
A Pharmacodynamics, Safety, and Pharmacokinetics Study of THN201 Versus Donepezil in Healthy Male Volunteers
|
Phase 1 | |
Not yet recruiting |
NCT05552729 -
Effects of Different Doses of Vitamin D on Cancer-related Cognitive Impairment in Patients With Gastrointestinal Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT03268109 -
COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years Old
|
||
Completed |
NCT03301402 -
Air Purifier to Improve Endothelial Function and Carotid Intima Thickness
|
N/A | |
Completed |
NCT03187353 -
IMProving Executive Function Study
|
Phase 4 | |
Completed |
NCT05395559 -
Prevalence and Recognition of Cognitive Impairment in Hospitalized Patients: a Flash Mob Study
|
||
Recruiting |
NCT04897334 -
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
|
N/A | |
Recruiting |
NCT04907565 -
Impact of Obesity on Post-operative Cognitive Dysfunction: Role of Adipose Tissue
|
||
Recruiting |
NCT05030285 -
Telehealth Psychotherapy for Anxiety in Persons With Cognitive Impairment
|
N/A |